Darra: “Fenfluramine, an innovative drug based on a serotonergic mechanism”

Invited as an expert, Head of UOC Child Neuropsychiatry of the Integrated University Hospital of Verona, she participated in the press conference announcing the reimbursement of UCB’s new fenfluramine-based drug, indicated in the treatment of epileptic seizures associated with the Syndrome of Dravet. Francesca Darra explains the mechanism of action and the results obtained so far in patients who are treated with this new drug.